These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression. Morales CR; Li DL; Pedrozo Z; May HI; Jiang N; Kyrychenko V; Cho GW; Kim SY; Wang ZV; Rotter D; Rothermel BA; Schneider JW; Lavandero S; Gillette TG; Hill JA Sci Signal; 2016 Apr; 9(422):ra34. PubMed ID: 27048565 [TBL] [Abstract][Full Text] [Related]
7. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy. Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of Histone Deacetylases Prevents Cardiac Remodeling After Myocardial Infarction by Restoring Autophagosome Processing in Cardiac Fibroblasts. Wang Y; Chen P; Wang L; Zhao J; Zhong Z; Wang Y; Xu J Cell Physiol Biochem; 2018; 49(5):1999-2011. PubMed ID: 30235443 [TBL] [Abstract][Full Text] [Related]
9. A novel histone deacetylase inhibitor Se-SAHA attenuates isoproterenol-induced heart failure via antioxidative stress and autophagy inhibition. Cheng T; Liu C; Wang Y; Li G; Feng L; Zhang S; Qi B; Cui J; Guo L; Cao L; Wang Y; Qi Z; Yang L Toxicol Appl Pharmacol; 2024 Jun; 487():116957. PubMed ID: 38735590 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Kee HJ; Sohn IS; Nam KI; Park JE; Qian YR; Yin Z; Ahn Y; Jeong MH; Bang YJ; Kim N; Kim JK; Kim KK; Epstein JA; Kook H Circulation; 2006 Jan; 113(1):51-9. PubMed ID: 16380549 [TBL] [Abstract][Full Text] [Related]
11. Overlapping and Divergent Actions of Structurally Distinct Histone Deacetylase Inhibitors in Cardiac Fibroblasts. Schuetze KB; Stratton MS; Blakeslee WW; Wempe MF; Wagner FF; Holson EB; Kuo YM; Andrews AJ; Gilbert TM; Hooker JM; McKinsey TA J Pharmacol Exp Ther; 2017 Apr; 361(1):140-150. PubMed ID: 28174211 [TBL] [Abstract][Full Text] [Related]
13. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Kong Y; Tannous P; Lu G; Berenji K; Rothermel BA; Olson EN; Hill JA Circulation; 2006 Jun; 113(22):2579-88. PubMed ID: 16735673 [TBL] [Abstract][Full Text] [Related]
14. Class I HDACs control a JIP1-dependent pathway for kinesin-microtubule binding in cardiomyocytes. Blakeslee WW; Lin YH; Stratton MS; Tatman PD; Hu T; Ferguson BS; McKinsey TA J Mol Cell Cardiol; 2017 Nov; 112():74-82. PubMed ID: 28886967 [TBL] [Abstract][Full Text] [Related]
15. Casein kinase-2α1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart. Eom GH; Cho YK; Ko JH; Shin S; Choe N; Kim Y; Joung H; Kim HS; Nam KI; Kee HJ; Kook H Circulation; 2011 May; 123(21):2392-403. PubMed ID: 21576649 [TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate ameliorates the cardiac hypertrophic response through inhibiting the activity of histone deacetylase-2. Yan H; Yi S; Zhuang H; Wu L; Wang DW; Jiang J Int J Mol Med; 2018 Mar; 41(3):1704-1714. PubMed ID: 29286094 [TBL] [Abstract][Full Text] [Related]
18. HDACs Regulate miR-133a Expression in Pressure Overload-Induced Cardiac Fibrosis. Renaud L; Harris LG; Mani SK; Kasiganesan H; Chou JC; Baicu CF; Van Laer A; Akerman AW; Stroud RE; Jones JA; Zile MR; Menick DR Circ Heart Fail; 2015 Nov; 8(6):1094-104. PubMed ID: 26371176 [TBL] [Abstract][Full Text] [Related]
19. Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats. Bogaard HJ; Mizuno S; Hussaini AA; Toldo S; Abbate A; Kraskauskas D; Kasper M; Natarajan R; Voelkel NF Am J Respir Crit Care Med; 2011 May; 183(10):1402-10. PubMed ID: 21297075 [TBL] [Abstract][Full Text] [Related]
20. Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy. Kee HJ; Kook H J Biomed Biotechnol; 2011; 2011():928326. PubMed ID: 21151616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]